- Clinical Trials
- April 2025
- 80 Pages
Global
From €1791EUR$2,000USD£1,527GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1791EUR$2,000USD£1,527GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1791EUR$2,000USD£1,527GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1791EUR$2,000USD£1,527GBP
- Report
- May 2025
- 199 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- April 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- June 2025
- 188 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- April 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- August 2024
- 146 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Drug Pipelines
- July 2024
- 80 Pages
Global
From €1791EUR$2,000USD£1,527GBP
- Report
- July 2024
- 100 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- August 2024
- 150 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- August 2024
- 295 Pages
Global
From €3224EUR$3,600USD£2,749GBP
- Report
- August 2024
- 128 Pages
North America
From €1344EUR$1,500USD£1,145GBP
- Report
- August 2024
- 142 Pages
Africa, Middle East
From €1344EUR$1,500USD£1,145GBP
- Report
- August 2024
- 141 Pages
Europe
From €1344EUR$1,500USD£1,145GBP
- Report
- August 2024
- 142 Pages
Asia Pacific
From €1344EUR$1,500USD£1,145GBP
- Report
- May 2022
- 93 Pages
Global
From €3448EUR$3,850USD£2,940GBP
- Report
- December 2023
- 111 Pages
Global
From €5329EUR$5,950USD£4,543GBP

The Artery Disease Drug market is a subset of the Cardiovascular Drugs market, which focuses on the treatment of diseases related to the arteries. These drugs are used to reduce the risk of heart attack, stroke, and other cardiovascular diseases. They work by reducing the amount of cholesterol and other fatty substances in the blood, as well as by preventing the formation of blood clots. Common drugs used to treat artery disease include statins, antiplatelet drugs, and anticoagulants. These drugs are often prescribed in combination with lifestyle changes, such as diet and exercise, to reduce the risk of cardiovascular disease.
Some of the major companies in the Artery Disease Drug market include Pfizer, Merck, Sanofi, AstraZeneca, and Novartis. Show Less Read more